Aimei Health Technology Co., Ltd.
Datakwaliteit: 67%
Ook genoteerd als
AFJKU
Nasdaq
AFJKR
Nasdaq
AFJK
Nasdaq
Financial Services
Holding & Investment Offices
€ 62,00
▲
€ 33,00
(113,79%)
Marktkapitalisatie: 379,55 M
Prijs
€ 62,00
Marktkapitalisatie
379,55 M
Dagbereik
€ 29,21 — € 85,00
52-Weeksbereik
€ 6,75 — € 130,37
Volume
465.021
Openen € 29,21
50D / 200D Gem.
€ 36,52
69,76% above
50D / 200D Gem.
€ 23,86
159,87% above
Quick Summary
Belangrijkste Punten
Earnings declined -93,28% over the past year
P/E of 117,10 — premium valuation
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-93,28%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-1,14%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,01
Interest CoverageN/A
Waardering
PE (TTM)
117,10
Boven sectorgemiddelde (11,15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (2153 peers)
Sectorvergelijking
vs Financial Services sector mediaan (2153 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 117,1 | 11,1 |
| P/B | — | 1,2 |
| ROE % | — | 9,2 |
| Net Margin % | — | 9,4 |
| Rev Growth 5Y % | — | 5,8 |
| D/E | — | 0,5 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -93,28% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | 3,24 M |
| ROE | N/A | ROA | 7,20% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | -1,14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,01 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2,75 M | Tangible Book Value | -3,44 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 117,10 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 379,55 M | Enterprise Value | 379,55 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,08 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | 171.389,0 | 2,55 M |
| EPS (Diluted) | 0,08 | — |
| Gross Profit | — | — |
| Operating Income | -28.459,0 | -1,06 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | — | — |
| Income Tax | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2023 | FY2024 |
|---|---|---|
| Total Assets | 70,47 M | 73,81 M |
| Total Liabilities | 714.841,0 | 1,51 M |
| Shareholders' Equity | -134.124,0 | -1,48 M |
| Total Debt | — | — |
| Cash & Equivalents | — | — |
| Current Assets | 580.717,0 | 30.384,0 |
| Current Liabilities | 24.841,0 | 816.994,0 |
{"event":"ticker_viewed","properties":{"ticker":"AFJK","listing_kind":"stock","pathname":"/stocks/afjk","exchange":"Nasdaq","country":"US"}}